This company develops AI agents that combine mechanistic reasoning with scalable automation to decode biological mechanisms and guide drug discovery experiments. They accelerate the translation of scientific insights to deliver transformative treatments more quickly to patients. Percept Biosciences provides actionable repurposing recommendations for patient advocacy groups and automates knowledge work for biotechs using their KoGent engine.
Funding
Funding not disclosed
Founders
Product
Problem
The drug development process frequently encounters failures, leading to valuable assets being shelved despite potential for repurposing. Identifying synergistic drug combinations across a broad spectrum of indications is a complex and time-consuming challenge.
Solution
Percept Biosciences leverages its proprietary Percept Engine to identify synergistic drug repurposing opportunities by integrating qualitative biological knowledge with quantitative data analysis. The platform systematically searches across all known indications to uncover optimal drug combinations, providing a data-driven strategy for clinical development and commercialization. This approach aims to resurrect shelved assets and accelerate the path to market for novel combination therapies. The Percept Engine's reasoning capabilities allow for a deeper understanding of molecular interactions and therapeutic potential.
Target Audience
Percept Biosciences targets pharmaceutical and biotechnology companies seeking to repurpose existing drug assets or discover novel combination therapies.
Features
- AI-driven platform for identifying synergistic drug repurposing opportunities
- Integration of qualitative biological knowledge with quantitative data analysis
- Comprehensive indication assessment for molecule fit and repositioning
- Proprietary algorithms for uncovering optimal drug combination strategies
- Focus on accelerating clinical development and commercialization pathways for combination therapeutics